|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S1
|
$48,687
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S2
|
$85,299
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
|
1U54CA221704-01A1
|
$1,050,067
|
OGUNWOBI, OLORUNSEUN
|
HUNTER COLLEGE
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
3R01CA227473-01S1
|
$293,469
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(ACCSIS) Accelerating Colorectal Cancer Screening through Implementation Science in Appalachia
|
1UG3CA233282-01
|
$770,562
|
DIGNAN, MARK
|
UNIVERSITY OF KENTUCKY
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
3R01CA206025-03S1
|
$52,355
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
3R21CA216830-02S1
|
$68,478
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
1/2 Langston University- UNTHSC Partnership for Cancer Research and Education
|
1P20CA233391-01
|
$210,731
|
QUINN, BYRON
|
LANGSTON UNIVERSITY
|
|
1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
|
2U54CA132383-11
|
$1,161,316
|
UNGUEZ, GRACIELA
|
NEW MEXICO STATE UNIVERSITY LAS CRUCES
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
3U54CA156734-08S1
|
$64,152
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
|
1U54CA221705-01A1
|
$1,671,024
|
MA, GRACE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-01S1
|
$47,364
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-02S1
|
$142,991
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
|
1P20CA221731-01A1
|
$287,404
|
CHOW, DIANA
|
UNIVERSITY OF HOUSTON
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S1
|
$62,420
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S2
|
$48,381
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233396-01
|
$1,008,781
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
11th AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA236113-01
|
$74,000
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
|
1P20CA233355-01
|
$255,958
|
VISHWANATHA, JAMBOOR
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
3P20CA202925-03S1
|
$104,165
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
|
2U54CA132381-11
|
$1,439,317
|
SIMON, JULIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-04S1
|
$48,872
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221696-02S1
|
$122,850
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
|
1P20CA221729-01A1
|
$258,006
|
MATZUK, MARTIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233444-01
|
$1,054,795
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233465-01
|
$1,141,251
|
CARPTEN, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
3D Model of Human Ewing Sarcoma
|
3R01CA180279-05S1
|
$221,019
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies
|
2R44CA203351-03
|
$240,368
|
MORGAN, LEE
|
DEKK-TEC, INC.
|
|
8th Great Lakes Nuclear Receptors Conference (GLNRC)
|
1R13CA236225-01
|
$5,000
|
DEHM, SCOTT
|
UNIVERSITY OF MINNESOTA
|
|
A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets
|
4K00CA223018-02
|
$80,244
|
MICKOLAJCZYK, KEITH
|
ROCKEFELLER UNIVERSITY
|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
2R44CA210817-02
|
$1,101,350
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
|
1U01CA233363-01
|
$587,514
|
COTE, RICHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A Computer Aided Diagnosis(CAD) Algorithm for Identification of Dysplasia in Patients with Barrett Esophagus
|
1R43CA232860-01
|
$217,888
|
NAMATI, EMAN
|
NINEPOINT MEDICAL, INC.
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
3U24CA076518-20S1
|
$1,060,626
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Galaxy?based multi?omic informatics hub for cancer researchers
|
3U24CA199347-03S1
|
$25,582
|
GRIFFIN, TIMOTHY
|
UNIVERSITY OF MINNESOTA
|
|
A high-throughput platform for neo-antigen based cancer immunotherapy
|
1R43CA233120-01
|
$299,917
|
XIAO, JUN
|
IMMUDX, LLC
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
3R01CA174851-05S1
|
$119,204
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A mechanistic dissection of the role of Eya3 in breast cancer metastasis
|
1F99CA234940-01
|
$36,490
|
ZHOU, HENGBO
|
UNIVERSITY OF COLORADO DENVER
|
|
A Mixed Methods Study to Explore the Effect of Hurricanes Irma and Maria on Cancer Care in Puerto Rico
|
1R21CA239456-01
|
$181,398
|
COLON, VIVIAN
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
A model of smoking relapse: an assessment of stress, discrimination and socioeconomic status
|
3R01CA190329-04S1
|
$115,391
|
WETTER, DAVID
|
UNIVERSITY OF UTAH
|
|
A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
7R21CA208618-02
|
$176,380
|
INTINI, GIUSEPPE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer
|
1K08CA234335-01
|
$196,414
|
THOMPSON, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
|
A New Small-Molecule Kinase Inhibitor for Breast Cancer
|
1R41CA235943-01
|
$300,000
|
HOLTZMAN, MICHAEL
|
NUPEAK THERAPEUTICS, INC.
|
|
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
|
7R01CA207645-03
|
$575,548
|
OSBORNE, JOSEPH
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Non-Contact Optical Patient and Beam Dosimetry System for Continuous in vivo Radiotherapy Verification
|
1R44CA232879-01
|
$252,666
|
WARE, WILLIAM
|
DOSEOPTICS, LLC
|
|
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
|
3R44CA165314-04S1
|
$1,400
|
LU, XUANYONG
|
IMCARE BIOTECH
|
|
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
|
2R44CA214076-02
|
$999,997
|
KEOGH, MICHAEL-CHRISTOPHER
|
EPICYPHER, INC.
|
|
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement
|
3U43CA221567-01S1
|
$49,951
|
PLACE, ROBERT
|
MIRECULE, INC.
|
|
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
|
4R44CA217591-02
|
$1,125,311
|
KAHN, STUART
|
SYNTRIX BIOSYSTEMS, INC.
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|